LobbyingCameco lobbying by quarter
Cameco CCJ's latest lobbying report covers Q2 2026, at $410K. The four quarters Q4 2025–Q3 2026 total $1.2M. Its first report covers Q4 2022; the issues it reports most are Energy/Nuclear and Foreign Relations.
CamecoCCJ
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $230K | 2 |
| Q1 2023 | $170K | 2 |
| Q2 2023 | $150K | 2 |
| Q3 2023 | $140K | 2 |
| Q4 2023 | $190K | 2 |
| Q1 2024 | $190K | 2 |
| Q2 2024 | $230K | 3 |
| Q3 2024 | $220K | 3 |
| Q4 2024 | $220K | 3 |
| Q1 2025 | $410K | 3 |
| Q2 2025 | $350K | 3 |
| Q3 2025 | $380K | 3 |
| Q4 2025 | $390K | 3 |
| Q1 2026 | $400K | 3 |
| Q2 2026 | $410K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Energy and nuclear$3.9M · 39 reports
- Foreign relations$195K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES39 reports
- SENATE39 reports
- Energy, Dept of34 reports
- Defense, Dept of (DOD)30 reports
- State, Dept of (DOS)29 reports
- Commerce, Dept of (DOC)15 reports
- Nuclear Regulatory Commission (NRC)15 reports
- White House Office13 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCameco | $2.6M | 15 quarters |
| Dentons US | $870K | 15 quarters |
| Bracewell | $640K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW SHAW | Legislative Assistant to Congressman Dennis Moore | Q2 2026 |
| KYLE SPENCER | Fellow, Governor Mike Pence (2013-2014); Law clerk, Governor Mike Pence (2015) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $250K |
| 07/08for Q2 | Bracewell | $100K |
| 07/07for Q2 | Dentons US | $60K |
| 04/20for Q1 | Bracewell | $100K |
| 04/20for Q1 | In-house | $240K |
| 04/16for Q1 | Dentons US | $60K |
| 01/20for Q4 2025 | Bracewell | $70K |
| 01/20for Q4 2025 | In-house | $260K |
| 01/12for Q4 2025 | Dentons US | $60K |
| 25/10/20for Q3 2025 | Bracewell | $70K |
| 25/10/20for Q3 2025 | In-house | $260K |
| 25/09/24for Q3 2025 | Dentons US | $50K |
| 25/07/21for Q2 2025 | Bracewell | $70K |
| 25/07/18for Q2 2025 | In-house | $230K |
| 25/07/15for Q2 2025 | Dentons US | $50K |
| 25/04/21for Q1 2025 | Bracewell | $70K |
| 25/04/21for Q1 2025 | In-house | $290K |
| 25/03/31for Q1 2025 | Dentons US | $50K |
| 25/01/17for Q4 2024 | In-house | $120K |
| 25/01/16for Q4 2024 | Bracewell | $70K |